Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Operating Leases (2019 - 2025)

Volitionrx filings provide 7 years of Operating Leases readings, the most recent being $276558.0 for Q4 2025.

  • On a quarterly basis, Operating Leases fell 56.27% to $276558.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $276558.0, a 56.27% decrease, with the full-year FY2025 number at $276558.0, down 56.27% from a year prior.
  • Operating Leases hit $276558.0 in Q4 2025 for Volitionrx, down from $351211.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $843443.0 in Q1 2022 to a low of $143998.0 in Q3 2021.
  • Median Operating Leases over the past 5 years was $378054.0 (2023), compared with a mean of $402495.6.
  • Biggest five-year swings in Operating Leases: surged 358.39% in 2022 and later plummeted 56.27% in 2025.
  • Volitionrx's Operating Leases stood at $217305.0 in 2021, then skyrocketed by 84.11% to $400091.0 in 2022, then dropped by 5.51% to $378054.0 in 2023, then soared by 67.29% to $632441.0 in 2024, then plummeted by 56.27% to $276558.0 in 2025.
  • The last three reported values for Operating Leases were $276558.0 (Q4 2025), $351211.0 (Q3 2025), and $417015.0 (Q2 2025) per Business Quant data.